Behavioral sleep medicine · 2025
Impact of Sleep-Disordered Breathing on Outcomes of Ischemic Stroke: A Systematic Review and Meta-Analysis.
СтатьяМетаанализСистематический обзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gu Jiali, Zhou Ying, Zhang Hailuo, Huo Jiahui
Аннотация
BACKGROUND: Sleep-disordered breathing (SDB) is common in ischemic stroke patients and may influence recovery and long-term outcomes. This systematic review and meta-analysis aims to evaluate the impact of SDB on clinical outcomes of ischemic stroke including complications, cognitive impairment, hospitalization, recurrent stroke, and mortality.
METHODS: A systematic search of PubMed, Embase, and Scopus databases was conducted to identify observational studies examining the relationship between SDB and outcomes in ischemic stroke patients. Random-effect models were used to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity was assessed using the I2 statistic.
RESULTS: A total of 30 observational studies were included. SDB was associated with significantly higher odds of hospitalization (OR: 6.14, 95% CI: 1.35-27.97) and mortality (OR: 3.39, 95% CI: 1.15-9.98). Moderate-to-severe SDB (AHI > 15) was linked to a higher incidence of adverse outcomes (OR: 1.03, 95% CI: 1.01-1.05). However, no significant associations were found for cognitive impairment (OR: 1.05, 95% CI: 0.73-1.51), complications (OR: 1.14, 95% CI: 0.84-1.55), or recurrent stroke (OR: 1.02, 95% CI: 0.19-5.47).
CONCLUSIONS: SDB significantly increases the risk of hospitalization and mortality in ischemic stroke patients. Early identification and management of SDB could improve clinical outcomes, though further research is needed to explore causal relationships and optimize interventions.Prospero Registration Number: CRD42024612023.
METHODS: A systematic search of PubMed, Embase, and Scopus databases was conducted to identify observational studies examining the relationship between SDB and outcomes in ischemic stroke patients. Random-effect models were used to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity was assessed using the I2 statistic.
RESULTS: A total of 30 observational studies were included. SDB was associated with significantly higher odds of hospitalization (OR: 6.14, 95% CI: 1.35-27.97) and mortality (OR: 3.39, 95% CI: 1.15-9.98). Moderate-to-severe SDB (AHI > 15) was linked to a higher incidence of adverse outcomes (OR: 1.03, 95% CI: 1.01-1.05). However, no significant associations were found for cognitive impairment (OR: 1.05, 95% CI: 0.73-1.51), complications (OR: 1.14, 95% CI: 0.84-1.55), or recurrent stroke (OR: 1.02, 95% CI: 0.19-5.47).
CONCLUSIONS: SDB significantly increases the risk of hospitalization and mortality in ischemic stroke patients. Early identification and management of SDB could improve clinical outcomes, though further research is needed to explore causal relationships and optimize interventions.Prospero Registration Number: CRD42024612023.